IMC Chicago
TEVA icon

IMC Chicago’s Teva Pharmaceuticals TEVA Stock Holding History

IMC Chicago’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Sell
36,515
-53,054
-59% -$1.77M ﹤0.01% 3595
2026
Q1 		$2.7M Buy
+89,569
New +$2.88M ﹤0.01% 2308
2025
Q3 		– Sell
-92,126
Closed -$1.62M – 3887
2025
Q2 		$1.54M Buy
92,126
+20,170
+28% +$325K ﹤0.01% 2195
2025
Q1 		$1.11M Buy
+71,956
New +$1.29M ﹤0.01% 2211
2024
Q4 		– Sell
-33,328
Closed -$606K – 3337
2024
Q3 		$601K Sell
33,328
-36,977
-53% -$647K ﹤0.01% 2329
2024
Q2 		$1.14M Buy
70,305
+45,157
+180% +$696K ﹤0.01% 1881
2024
Q1 		$355K Buy
+25,148
New +$317K ﹤0.01% 2181
2023
Q4 		– Sell
-91,254
Closed -$852K – 1934
2023
Q3 		$931K Sell
91,254
-41,676
-31% -$388K ﹤0.01% 1248
2023
Q2 		$1M Sell
132,930
-96,919
-42% -$786K ﹤0.01% 1055
2023
Q1 		$2.03M Buy
229,849
+125,574
+120% +$1.24M ﹤0.01% 845
2022
Q4 		$951K Buy
104,275
+27,762
+36% +$242K ﹤0.01% 1010
2022
Q3 		$617K Sell
76,513
-110,485
-59% -$977K ﹤0.01% 1047
2022
Q2 		$1.41M Buy
186,998
+56,245
+43% +$490K ﹤0.01% 766
2022
Q1 		$1.23M Sell
130,753
-110,134
-46% -$919K ﹤0.01% 874
2021
Q4 		$1.93M Buy
240,887
+130,638
+118% +$1.18M ﹤0.01% 830
2021
Q3 		$1.07M Sell
110,249
-21,428
-16% -$201K ﹤0.01% 981
2021
Q2 		$1.3M Buy
131,677
+49,265
+60% +$521K ﹤0.01% 859
2021
Q1 		$951K Buy
+82,412
New +$945K ﹤0.01% 863
2019
Q2 		– Sell
-22,168
Closed -$267K – 770
2019
Q1 		$348K Buy
+22,168
New +$391K ﹤0.01% 578

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

IMC Chicago's TEVA Position: Q2 2026 in Review

IMC Chicago reduced its Teva Pharmaceuticals (TEVA) stake by 59% in Q2 2026, selling an estimated $1.77M and leaving 36,515 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #3595.

IMC Chicago first reported a position in TEVA in Q1 2019 and has held it in 19 quarters since. The position peaked at $2.7M in Q1 2026. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • IMC Chicago held 36,515 shares of Teva Pharmaceuticals worth $1.24M as of Q2 2026.
  • IMC Chicago sold 53,054 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.77M.
  • Teva Pharmaceuticals made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3595 holding.
  • IMC Chicago first reported a position in Teva Pharmaceuticals in Q1 2019 and has held it in 19 quarters since.
  • IMC Chicago's Teva Pharmaceuticals position peaked at $2.7M in Q1 2026.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.